Physician profile
Terry M Phillis
NPI 1750359030
$6,719.52
in general payments reported to CMS, 2019-2025
38 companies · $956 in 2025
The $956 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $384 · 2021: $584 · 2022: $604 · 2023: $641 · 2024: $2,807 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,959 · Travel and Lodging: $1,365 · Education: $79.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,959.42 |
| Travel and Lodging | $1,365.40 |
| Education | $79.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,309.84 | 2024 | Aquabeam System |
| Bluewind Medical | $789.22 | 2024 | Revi |
| Abbvie INC. | $606.71 | 2019-2025 | |
| Astellas Pharma US INC | $566.11 | 2019-2025 | Xtandi |
| Allergan, INC. | $512.93 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $432.60 | 2019-2025 | |
| Janssen Biotech, INC. | $368.17 | 2019-2025 | Erleada, Balversa, Akeega |
| Intuitive Surgical, INC. | $230.60 | 2022-2024 | Da Vinci Surgical System |
| Endo Pharmaceuticals INC. | $229.63 | 2019-2023 | Xiaflex, Aveed |
| Antares Pharma, INC. | $227.50 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Healthtronics Stone Solutions, LLC | $200.68 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Axonics, INC. | $176.53 | 2022-2024 | Axonics, Bulkamid |
| Pfizer INC. | $166.57 | 2019-2025 | |
| Coloplast Corp | $95.12 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $80.93 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $66.71 | 2024-2025 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $58.79 | 2023-2025 | Pylarify |
| Boston Scientific Corporation | $57.66 | 2019-2024 | Rezum Generator |
| Halozyme INC | $50.88 | 2023 | |
| Urovant Sciences INC | $48.55 | 2021-2022 | |
| Ethicon US, LLC | $45.77 | 2021-2024 | Surgiflo Hemostatic Matrix |
| 180 Medical, INC. | $42.95 | 2025 | Gentlecath Glide, Gentlecath |
| Myovant Sciences INC. | $40.08 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $38.66 | 2020-2021 | |
| Urogen Pharma, INC. | $37.44 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $35.36 | 2024 | Orgovyx |
| Immunitybio, INC. | $32.27 | 2025 | |
| Conmed Corporation | $25.89 | 2019 | |
| Travere Therapeutics, INC. | $22.75 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $22.33 | 2024 | Prolaris |
| Neotract INC. | $22.25 | 2019 | |
| Laborie Medical Technologies Corp. | $21.29 | 2025 | |
| Medtronic USA, INC. | $15.79 | 2019 | |
| Verity Pharmaceuticals INC. | $14.05 | 2025 | Tlando |
| Smith+Nephew, INC. | $13.98 | 2025 | N/A, Lens, Intellio Link Werewolf |
| Clovis Oncology, INC. | $12.93 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Phillis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.